COVID-19 related concerns of people with long-term respiratory conditions: a qualitative study

Posted on | Posted on John Murphy | Leave a Comment on COVID-19 related concerns of people with long-term respiratory conditions: a qualitative study

Authors: Keir E. J. Philip,  Bradley Lonergan, Andrew Cumella, Joe Farrington-Douglas, Michael Laffan & Nicholas S. Hopkinson BMC Pulmonary Medicine volume 20, Article number: 319 (2020)  Abstract Background The COVID-19 pandemic is having profound psychological impacts on populations globally, with increasing…[...]

The characteristics and evolution of pulmonary fibrosis in COVID-19 patients as assessed by AI-assisted chest HRCT

Posted on | Posted on John Murphy | Leave a Comment on The characteristics and evolution of pulmonary fibrosis in COVID-19 patients as assessed by AI-assisted chest HRCT

Authors: Jia-Ni Zou , Liu Sun , Bin-Ru Wang , You Zou , Shan Xu, Yong-Jun Ding, Li-Jun Shen, Wen-Cai Huang, Xiao-Jing Jiang, Shi-Ming Chen  Published: March 23, 2021 https://doi.org/10.1371/journal.pone.0248957 Abstract The characteristics and…[...]

The incidence, clinical characteristics, and outcomes of pneumothorax in hospitalized COVID-19 patients: A systematic review

Posted on | Posted on John Murphy | Leave a Comment on The incidence, clinical characteristics, and outcomes of pneumothorax in hospitalized COVID-19 patients: A systematic review

Authors: Woon H. Chong,a,⁎Biplab K. Saha,bKurt Hu,c and Amit Chopraa Abstract Background Pneumothorax has been frequently described as a complication of COVID-19 infections. Objective In this systematic review, we describe the incidence,…[...]

Informed consent disclosure to vaccine trial subjects of risk of COVID‐19 vaccines worsening clinical disease

Posted on | Posted on John Murphy | Leave a Comment on Informed consent disclosure to vaccine trial subjects of risk of COVID‐19 vaccines worsening clinical disease

Authors: Timothy Cardozo 1 and Ronald Veazey 2 Abstract Aims of the study Patient comprehension is a critical part of meeting medical ethics standards of informed consent in study designs. The aim of the…[...]

U.S. probing Moderna vaccine for higher heart inflammation risk – Washington Post

Posted on | Posted on John Murphy | Leave a Comment on U.S. probing Moderna vaccine for higher heart inflammation risk – Washington Post

Authors: Reporting by Shubham Kalia in Bengaluru; Editing by Krishna Chandra Eluri and Ramakrishnan M. Aug 19 (Reuters) - U.S. health officials are investigating reports that Moderna Inc's (MRNA.O) COVID-19 vaccine may…[...]

Scientists blast U.S. push for Covid vaccine booster shots as premature, say data isn’t compelling

Posted on | Posted on John Murphy | Leave a Comment on Scientists blast U.S. push for Covid vaccine booster shots as premature, say data isn’t compelling

PUBLISHED THU, AUG 19 20211:44 PM EDTUPDATED THU, AUG 19 20216:27 PM EDT Authors: Berkeley Lovelace Jr.@BERKELEYJR KEY POINTS Scientists sharply criticized the Biden administration’s push to widely distribute Covid…[...]

US Covid-19 Breakthrough Infections-are-Uncommon Rising Considerably and D-19 Breakthrough Infections are Uncommon, Rising Considerably, and Sort of Okay

Posted on | Posted on John Murphy | Leave a Comment on US Covid-19 Breakthrough Infections-are-Uncommon Rising Considerably and D-19 Breakthrough Infections are Uncommon, Rising Considerably, and Sort of Okay

Authors: PETER WEBER 5:20 AM The Biden administration is advising eight-month booster shots for Americans vaccinated with the Pfizer and Moderna COVID-19 vaccines because the Delta variant, which now accounts for about 98.8…[...]

Covid Vaccines Are Less Effective Against Delta, Large Study Finds Naomi Kresge Bookmark August 19 2021, 4:31 AM

Posted on | Posted on John Murphy | Leave a Comment on Covid Vaccines Are Less Effective Against Delta, Large Study Finds Naomi Kresge Bookmark August 19 2021, 4:31 AM

Authors: Naomi Kresge Copyright © BloombergQuintCopyright © Covid-19 vaccines are less effective against the delta variant, according to results in the U.K. from one of the largest real-world studies into…[...]

Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial

Posted on | Posted on John Murphy | Leave a Comment on Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial

Authors: Julio Vallejos, Rodrigo Zoni, María Gabriela Aguirre  Abstract Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease…[...]